Drug Discovery Market Revenues to Reach USD 129.21 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
July 28, 2023 09:30 ET
|
Mordor Intelligence
Hyderabad, July 28, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Drug Discovery Market Report (2023-2028),” the market is estimated at USD 93.91 billion in 2023. It is...
Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis
July 27, 2023 16:00 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with...
Florida Cancer Specialists & Research Institute First in Palm Beach County To Offer Targeted Radioligand Therapy for Metastatic Prostate Cancer
October 12, 2022 13:40 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute locations in Palm Beach County are now offering Pluvicto ™, the first targeted radioligand...
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Ebix, Intuit, and Argo and Encourages Investors to Contact the Firm
July 20, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
Bragar Eagel & Squire, P.C. Is Investigating Digital World, Generac, Novartis, and Cognyte and Encourages Investors to Contact the Firm
July 15, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Digital World Acquisition...
Bragar Eagel & Squire, P.C. Is Investigating the WWE, Digital World, Generac, and Novartis and Encourages Investors to Contact the Firm
July 10, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against World Wrestling...
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Unity Software, Gap, and Cassava and Encourages Investors to Contact the Firm
July 04, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
Bragar Eagel & Squire, P.C. Is Investigating Novartis, Medallion, RBB, and Agrify and Encourages Investors to Contact the Firm
June 24, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Novartis AG (NYSE: NVS),...
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
June 13, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA),...
Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm
June 08, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA),...